Ozempic, MRI machines and flat screen televisions all emerged out of fundamental research decades earlier — the very types of ...

Hims & Hers continues to sell compounded semaglutide, the active ingredient in Novo’s Wegovy and Ozempic drugs, and these ...

Veterinarian Cath Watson says pet obesity's been a problem for a while and it's getting worse - but these drugs wouldn't be her first choice. She says when they're bugging for food, try playing with ...

Eli Lilly LLY has been on an acquisition spree since the beginning of this year to bolster its pipeline, which should drive ...

After losing its leading position in obesity, changing its CEO and triggering a major company reorganization, the pressure is ...

Constellation Brands, Inc. is a growing, high-quality beer business trading at a discount to fair value. Click here to read ...

Lilly predicts it will achieve an adjusted profit of between $23.00 and $23.70 per share this year, an increase on its ...

Once a niche asset class serving grocers and food processors, cold storage has evolved into one of the most dynamic, data-driven, and capital-intensive property types in commercial real estate.

Pfizer is suing over some unsolicited competition in its nearly $5 billion bid to buy the drugmaker Metsera. New York-based Pfizer said Friday after markets closed that it was suing Metsera and ...

Lilly moved first. In January 2024, it launched LillyDirect, linking patients with telehealth providers and home delivery for its diabetes and weight-management portfolio. Pfizer followed in August ...

The market for obesity and diabetes treatments remains scorching hot, funneling billions in sales to Eli Lilly.

Despite success with injectable drugs pharma companies are investing heavily in tablets, long considered the holy grail of ...